Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide vs Hydroxychloroquine for Severe Thrombocytopenia in SLE
NCT02444728Phase 3Terminated
- Sponsor
- Chinese SLE Treatment And Research Group
- Start
- Jul 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, cyclophosphamide in systemic lupus erythematosus (SLE), sponsored by Chinese SLE Treatment And Research Group. Started Jul 2015; status: terminated.
02
Drugs
hydroxychloroquinecyclophosphamide
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02444728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444728.